|
1
|
Mazzone T, Chait A and Plutzky J:
Cardiovascular disease risk in type 2 diabetes mellitus: Insights
from mechanistic studies. Lancet. 371:1800–1809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miettinen H, Lehto S, Salomma V, Mähönen
M, Niemelä M, Haffner SM, Pyörälä K and Tuomilehto J: The FINMONICA
Myocardial Infarction Register Study Group: Impact of diabetes on
mortality after the first myocardial infarction. Diabetes Care.
21:69–75. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Groote P, Lambin N, Mouquet F, Plichon
D, McFadden E, Van Belle E and Bauters C: Impact of diabetes
mellitus on long-term survival in patients with congestive heart
failure. Eur Heart J. 25:656–662. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai L and Kang YJ: Cell death and diabetic
cardiomyopathy. Cardiovasc Toxicol. 3:219–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Zhang T, Dai H, Liu G, Wang H, Sun
Y, Zhang Y and Ge Z: Endoplasmic reticulum stress is involved in
myocardial apoptosis of streptozocin-induced diabetic rats. J
Endocrinol. 196:565–572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ou HC, Tzang BS, Chang MH, Liu CT, Liu HW,
Lii CK, Bau DT, Chao PM and Kuo WW: Cardiac contractile dysfunction
and apoptosis in streptozotocin-induced diabetic rats are
ameliorated by garlic oil supplementation. J Agric Food Chem.
58:10347–10355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goll DE, Thompson VF, Li H, Wei W and Cong
J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inserte J, Garcia-Dorado D, Hernando V and
Soler-Soler J: Calpain-mediated impairment of Na+/K+-ATPase
activity during early reperfusion contributes to cell death after
myocardial ischemia. Circ Res. 97:465–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galvez AS, Diwan A, Odley AM, Hahn HS,
Osinska H, Melendez JG, Robbins J, Lynch RA, Marreez Y and Dorn GW
II: Cardiomyocyte degeneration with calpain deficiency reveals a
critical role in protein homeostasis. Circ Res. 100:1071–1078.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bajaj G and Sharma RK: TNF-alpha-mediated
cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem
Biophys Res Commun. 345:1558–1564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang CH, Lu J, Yu XJ, Sun L and Zang WJ:
Ameliorative effect of Captopril and Valsartan on an animal model
of diabetic cardiomyopathy. Biol Pharm Bull. 31:2045–2049. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guan SJ, Ma ZH, Wu YL, Zhang JP, Liang F,
Weiss JW, Guo QY, Wang JY, Ji ES and Chu L: Long-term
administration of fasudil improves cardiomyopathy in
streptozotocin-induced diabetic rats. Food ChemToxicol.
50:1874–1882. 2012. View Article : Google Scholar
|
|
13
|
Symeonides P, Koulouris S, Vratsista E,
Triantafyllou K, Ioannidis G, Thalassinos N and Katritsis D: Both
ramipril and telmisartan reverse indices of early diabetic
cardiomyopathy. A comparative study. Eur J Echocardiogr. 8:480–486.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akins RE and Tuan RS: Measurement of
protein in 20 seconds using a microwave BCA assay. Biotechniques.
12:496–499. 1992.PubMed/NCBI
|
|
15
|
Gavrieli Y, Sherman Y and Ben-Sasson SA:
Identification of programmed cell death in situ via specific
labeling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solski LV and Longyhore DS: Prevention of
type 2 diabetes mellitus with angiotensin-converting-enzyme
inhibitors. Am J Health Syst Pharm. 65:935–940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Araujo Rodrigues G, de Faria Granato K,
Lima WG, Bda Pádua C, Rossoni JV Jr, Souza AA, Chianca-Júnior D,
Silva ME, Pedrosa ML, Chaves MM and Costa DC: Effect of captopril
and the bradykinin-PKC pathway on ROS production in type 1 diabetic
rats. Can J Physiol Pharmacol. 89:923–933. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okoshi K, Guimarães JF, Di Muzio BP,
Fernandes AA and Okoshi MP: Diabetic cardiomyopathy. Arq Bras
Endocrinol Metabol. 51:160–167. 2007.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bojunga J, Nowak D, Mitrou PS, Hoelzer D,
Zeuzem S and Chow KU: Antioxidative treatment prevents activation
of death-receptor- and mitochondrion-dependent apoptosis in the
hearts of diabetic rats. Diabetologia. 47:2072–2080. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P and
Yu DM: Attenuation of myocardial apoptosis by alpha-lipoic acid
through suppression of mitochondrial oxidative stress to reduce
diabetic cardiomyopathy. Chin Med J (Engl). 122:2580–2586.
2009.PubMed/NCBI
|
|
21
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walensky LD: Bcl-2 in the crosshairs:
Tipping the balance of life and death. Cell Death Differ.
13:1339–1350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar S, Prasad S and Sitasawad SL:
Multiple antioxidants improve cardiac complications and inhibit
cardiac cell death in streptozotocin-induced diabetic rats. PLoS
One. 8:e670092013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boatright KM and Salvesen GS: Caspase
acrivation. Biochem Soc Symp. 233–242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Donovan M and Cotter TG: Control of
mitochondrial integrity by Bcl-2 family members and
caspase-independent cell death. Biochim Biophys Acta. 1644:133–147.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai L, Li W, Wang G, Guo L, Jiang Y and
Kang YJ: Hyperglycemia-induced apoptosis in mouse myocardium:
Mitochondrial cytochrome C-mediated caspase-3 activation pathway.
Diabetes. 51:1938–1948. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cesario DA, Brar R and Shivkumar K:
Alterations in ion channel physiology in diabetic cardiomyopathy.
Endocrinol Metab Clin North Am. 35:601–610. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Li Y, Feng Q, Arnold M and Peng T:
Calpainactivation contributes to hyperglycaemia-induced apoptosis
in cardiomyocytes. Cardiovasc Res. 84:100–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao G and Dou QP: N-terminal cleavage of
bax by calpain generates a potent proapoptotic 18-kDa fragment that
promotes bcl-2-independent cytochrome C release and apoptotic cell
death. J Cell Biochem. 80:53–72. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gil-Parrado S, Fernández-Montalván A,
Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA,
Auerswald EA, Welsh K, Reed JC, et al: Ionomycin-activated calpain
triggers apoptosis. A probable role for Bcl-2 family members. J
Biol Chem. 277:27217–27226. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang CH, Lu J, Yu XJ, Sun L and Zang WJ:
Ameliorative effect of Captopril and Valsartan on an animal model
of diabetic cardiomyopathy. Biol Pharm Bull. 31:2045–2049. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Connelly KA, Boyle AJ and Kelly DJ:
Angiotensin II and the cardiac complications of diabetes mellitus.
Curr Pharm Des. 13:2721–2729. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu Z, Tepel M, Neusser M, Mehring N and
Zidek W: Effect of captopril on vasoconstriction and Ca2+ fluxes in
aortic smooth muscle. Hypertension. 22:806–811. 1993. View Article : Google Scholar : PubMed/NCBI
|
